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1. Introduction 
Bacteriophage are bacterial viruses which may attack and destroy bacterial cells. While 
many have a narrow host range and are used in sub-typing techniques, some infect many 
members of a genus or species and these have been used to develop rapid detection 
methods for a variety of bacterial pathogens (Rees and Loessner, 2008). The use of 
bacteriophage (or phage) in assays for detecting bacteria was first reported over half a 
century ago when an assay to detect Salmonella using phage Felix 01 was described by 
Cherry et al. (1954). Since then other bacteriophage-based detection methods have been 
developed that take advantage of the specificity of the host-phage interaction and its ability, 
once inside the host, to replicate rapidly. This is particularly useful when studying slow-
growing organisms such as Mycobacterium tuberculosis and other slow growing mycobacteria 
such as Mycobacterium avium subsp. paratuberculosis (see Stanley et al., 2007; Grant & Rees, 
2009, Botsaris et al., 2010). This chapter will provide an introduction to phage biology and 
will then describe the different phage-based detection methods that have been described for 
M. tuberculosis – including one that has been developed into a commercial product. In 
addition adaptations of the phage test are described that allow the antibiotic sensitivity of 
isolates to be rapidly determined, and also how a further modification can be used to allow 
rapid estimation of viable cell number. However, all these indirect methods have their 
limitations and these too will be discussed in each case.  
2. Mycobacteriophage  
Mycobacteriophage, which are phage that infect any members of the Mycobacterium genus, 
were first isolated and characterized by Gardner and Weiser in 1947 and further 
investigation was prompted in the 1950s by their utility in typing of clinical isolates. Phage 
typing is a method used to sub-type members of a bacterial species based the sensitivity of a 
particular host strain to a panel of bacteriophage that have been shown to have a limited 
host range within the group (see Rees and Loessner, 2008, for a description of this method). 
So far over 200 different mycobacteriophage have been described, infecting a broad variety 
of mycobacterial hosts and these have been isolated from a variety of environmental 
sources, such as soil or surface water (Froman et al., 1954; Caroli & Avio, 1975), and stool 
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and resection specimens of patients with tuberculosis or sarcoidosis (Mankiewicz, 1961; 
Mankiewicz & Liivak, 1967). The collection of Mycobacteriophage is continually being 
expanded due to an education programme developed by researchers at the University of 
Pittsburgh, supported by the Howard Hughes Medical Institute Science Education Alliance. 
This has recently resulted in the publication of a multi-author paper describing the isolation, 
sequencing and comparative genomic analysis of 18 new mycobacteriophages isolated from 
geographically distinct locations by freshmen attending Universities across within the 
United States (Pope et al., 2011).  
Like all viruses, phage consist of a nucleic acid core and a protein coat, and considerable 
variation in structure has been reported. However all mycobacteriophage that have been 
described to date are double-stranded DNA viruses consisting of icosahedral heads with a 
tail which may be either short or long and either flexible (Siphoviridae) or contractile 
(Myoviridae) (Hatfull et al., 2008; see Figure 1). These tail structures play an essential role in 
host cell recognition and penetration of the bacterial cell wall structure. The comparative 
genomic analysis of mycobacteriophage reveals that they have relatively large genomes 
(average length approx. 70 kbp), contain large numbers of previously unidentified genes, 
and are highly diverse at both the nucleotide and amino acid sequence levels (Pedulla et al., 
2003; Hatfull et al., 2010; Pope et al., 2011). Once inside the host cell the phage take over the 
host cell biosynthetic machinery and use this to replicate themselves, usually producing 
hundreds of progeny phage per infected cell (Figure 2). At the end of the replication cycle 
many phage produce enzymes (lysins) which degrade the cell wall and result in the lysis of 
the host cell and release of the progeny phage. However some phage do not always enter 
this lytic cycle. Instead, after entering the cell, they can enter a dormant state resulting in a 
latent infection. This state is known as lysogeny, but these lysogenic (or temperate) phage 
can be induced back into the lytic cycle, often in response to environmental conditions that 
either damage cellular structures or induce a stress response in the host cell (Figure 2). Both 
lytic and lysogenic Mycobacteriophage have been identified.  
 
Fig. 1. Common Morphotypes of Mycobacteriophage 
Myoviridae (panel A) typically have short, rigid contractile tails which often have associated 
tail fibres. Siphoviridae (panle B) have longer, flexible, non-contractile tails which 
termimates in a base-plate structure and tail fibres are absent. Both types of phage have 
double stranded DNA genomes. The majority of Mycobacteriophage are Siphoviridae.  
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Fig. 2. The Bacteriophage Replication Cycle 
Schematic representation of the Lytic and the Lysogenic Cycles. Lytic Cycle: Infection is 
mediated via receptors found in the phage tail structures. During infection the 
bacteriophage inserts the genomic DNA located inside the virus capsid into the cell (1 & 2) 
and then it takes over the cell replication machinery and directs the synthesis of 
bacteriophage nucleic acids and proteins (3 & 4 and 5). Finally the phage produces enzymes 
(lysins) that breaks open the cell and the mature bacteriophage particles are released (6). 
Lysogenic Cycle: adsorption occurs in the same way (1) but the bacteriophage DNA is not 
replicated and instead integrates into the host cell’s genome (2b). It is then replicated along 
with the host cell DNA at cell division and the lytic genes are not expressed (3b and 4b). 
When the cell divides a copy of the bacteriophage DNA is transferred along with the host 
chromosome (5b). Following induction into the lytic phase, the integrated phage DNA is 
excised from the host cell genome and the lytic genes are then expressed leading to phage 
replication.  
3. Use of phage in detection assays  
Mycobacteriophage have been used to detect slow fastidious mycobacteria, such as 
members of the TB complex. The main two techniques developed for detection of 
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mycobacteria using phage are recombinant Reporter Phage and the Phage Amplification 
Assay (PAA), also known as Phage Amplified Biologically (PhaB) assay. These two methods 
differ in how the host cell is detected at the end of the assay and both are described in more 
detail in the following sections.  
3.1 Reporter Phage assays for mycobacteria  
The Reporter Phage detection method uses genetic engineering to introduce a reporter gene 
into a phage genome. Since genes are not expressed inside the virion particle, no signal is 
produced from the reporter gene until it enters a host cell during infection. At this point the 
reporter gene is expressed along with the phage replication genes and this can be detected 
to indicate that an infection event has occurred (see Figure 3). The limitation here is the 
packaging constraint of the phage being used; this is the natural limit on the size of phage 
genome that can be packaged into a phage head. If the size of the gene being introduced into 
the phage exceeds the packaging constraint, the recombinant phage particles are defective. 
However the firefly luciferase reporter gene (Fflux or luc) has been successfully introduced 
into a number of mycobacteria phage (Jacobs et al., 1993; Sarkis et a., 1995; Pearson et al., 
1996; Riska et al., 1997). This enzyme requires a source of ATP to produce light 
(bioluminescence), and this is provided by the infected cell. When the luciferin substrate for 
the enzyme is added (exogenously) the light can be sensitively detected by a luminometer.  
The first Mycobacterial Reporter Phage described were based on the lytic phage TM4 since it 
was argued that a lytic phage would not be able to enter the dormant lysogenic state and 
therefore would produce high levels of reporter signal. However but it was found that these 
lysed the Mycobacterium cells too rapidly so that only low levels of luciferase were produced. 
This reduced the limit of detection when using this phage to approximately 104 
mycobacterial cells (Jacobs et al., 1993). The same group also constructed a reporter phage 
using the temperate phage L5 and found that when the phage integrated into the 
chromosome there was prolonged expression of the reporter gene and this then reduced the 
limit of detection to approximately 102 cells after a 40 h incubation period, or 103 cells after 
20 h (Sarkis et al., 1995). Although this demonstrated for the first time that reporter phage 
could be used to rapidly and sensitively detect Mycobacteria, this phage had a limited host 
range and therefore could not be developed as a practical test for M. tuberculosis. Instead the 
TM4-based reporter phage was improved by changing the site of insertion of the Fflux gene 
in the phage genome and isolating mutants of the phage to improve host range. This lead to 
the isolation of a TM4-based reporter phage that could detect as few as 120 Mycobacterium 
bovis BCG after 12 h of incubation (Carriere et al., 1997) which is significantly faster than any 
culture-based method can achieve and when tested on clinical samples it was shown that 
smear-positive sputum samples could be detected within 24-48 h (Riska et al., 1997). One 
limitation of the Reporter Phage assay for direct identification of M. tuberculosis in clinical 
samples is that these phage are able to infect a number of species of Mycobacterium, for 
instance TM4 also infects M. bovis and members of the M. avium complex (Timme and 
Brennan, 1984). This results in reduced specificity of the assay and hence produces false-
positive test results. To overcome this, the reporter phage have been used in combination 
with p-nitro-a-acetylamino-b-hydroxy propiophenone (NAP) which specifically inhibits the 
growth of M. tuberculosis complex bacteria (Eidus et al. 1960). Parallel samples, with and 
without the addition of NAP, are used and the results of the Reporter Phage assay 
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compared. If light is produced from both samples then the organism detected is not M. 
tuberculosis. However if light is suppressed in the sample containing NAP, this indicates 
that M. tuberculosis cells have been detected (Riska et al. 1997). Using this combination of 
tests, Banaiee et al. (2001) reported that 94% of strains tested could be correctly identified.  
 
Fig. 3. General Schematic for Reporter Phage Assays 
Schematic representation for Reporter Phage Assays. Following the insertion of the reporter 
gene into the phage genome the phage infects the targeted host cell. The reporter gene is 
then expressed from the phage genome and as the reporter protein accumulates the signal is 
detected.  
Although these initial reports were promising there have been very few recent reports of the 
use of reporter phage as a diagnostic tool for TB. Recently, Dusthackeer et al. (2008) reported 
the construction of a new Fflux Reporter Phage using the temperate phage, Che12 – again 
arguing that integration of these phage would produce more sustained light levels – and 
also using promoters to direct the expression of the Fflux that were predicted to be more 
highly expressed in dormant bacilli (isocitrate lyase (icl) and alpha crystallin protein (acr)). 
They also re-engineered the promoter sequences gene in the defective TM4-based phage 
phAE129 (Carriere et al., 1997) to determine if light output could be improved. Interestingly, 
by comparing the results obtained for the two phage they showed that while these 
promoters did increase light output when the phage infected dormant cells, the Che12 
Reporter Phage only poorly infected dormant bacilli. This is probably because it lacks a 
peptidoglycan hydrolase TM3 motif found in the TM4 tape- measure protein and this is 
required to allow phage to efficiently infect M. smegmatis in stationary phase when it has a 
thicker or more highly cross-linked peptidoglycan layer.  
Two new Reporter Phage constructs have also been described which have been engineered 
to contain genes encoding the fluorescent proteins GFP or ZsYellow (Piuri et al., 2009). 
These were introduced into the conditionally-replicating TM4 derivative phAE87 under the 
control of the constitutive M. bovis BCG Hsp60 promoter to create the fluorophage 
phAE87::hsp60-EGFP and phAE87::hsp60-ZsYellow. However these were evaluated for use as 
a rapid, semi-automoated method for determining antibiotic sensitivity of M. tuberculosis 
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isolates rather than as a detection method (see section 4) and this seems to be now accepted 
as the most useful application of the Reporter Phage in TB diagnostics.  
However there may still be examples where the Reporter Phage may provide a useful tool 
for the detection of other types of pathogenic Mycobacteria. For instance Sasahara et al. 
(2004) described the use of Reporter Phage for the detection of the cattle pathogen 
Mycobacterium avium subspecies paratuberculosis (MAP). Using phage phAE85 >1000 cells 
/mL were detectable within 24-48 h. When applied to milk, the authors reported that MAP 
was detectable at 100 cells/ml in skim milk and 1,000 cells/ml in whole milk. While this is a 
useful demonstration of the rapid detection of pathogenic Mycobacteria in a food matrix, it 
is unlikely that this will be adopted as a rapid testing method by the food industry since 
these Reporter Phage are considered to be GMOs and any laboratory using them is required 
to work according to the local GM regulations, and the cost of implementing these is not 
generally compatible with food microbiology testing.  
3.2 Phage amplification assays  
Unlike the Reporter Phage assays, the PAA or PhaB assays do not use recombinant phage. 
In these assays a positive indication of the presence of mycobacteria is the formation of 
plaques at the end of the assay. There have been several variations of these types of assay 
published but the general principle is a phage protection assay (see Rees and Loessner, 
2008). To initiate the assays the sample containing the target cell is first mixed with a high 
titre of the bacteriophage. The samples are then incubated to allow time for cell infection to 
occur and for the phage to enter the eclipse phase. At this point any exogenous phage that 
have not entered an appropriate host cell are destroyed by the addition of a virucide. 
Various chemicals have been described that can be used as the virucide, but the essential 
feature of the chemical chosen is fast inactivation of phage particles while having no effect 
on the viability of the host cells (Stewart et al., 1998). These internalized phage now must be 
detected, and in its simplest form the phage released at the end of the lytic cycle are detected 
by the formation of plaques (areas of no growth) in a bacterial lawn. Many of the 
Mycobacteria phage, such as TM4 and D29, have a broad host range and can also infect the 
fast growing, non-pathogen M. smegmatis. Hence this is often used as a rapidly growing host 
to produce lawns of bacterial to detect the newly released phage (see Figure 4). 
This assay has been produced as commercial kits (the FASTplaqueTBTM or Phage Tek MB 
assays; www.biotec.com) and also “in house” versions have been described (McNerney et 
al., 2004) and its performance has been extensively reviewed (see Kalantri et al., 2005; 
Palomino, 2005; Dinnes et al., 2007). The assessment of the performance of these tests have 
been variable, with some groups reporting that that they perform very well (Albert et al., 
2002; Muzaffar et al., 2002; Shenai et al., 2002; Kiraz et al., 2007) while others have reported 
problems with sample contamination leading to loss of results (Mbulo et al. 2004; Bonnet et 
al., 2009), and hence decreased sensitivity of the test. This problem has been addressed by 
the manufacturers by the introduction of an antibiotic supplement containing nystatin, 
oxacillin and aztreonam (NOA) which suppresses the growth of a wide range of Gram-
positive and Gram-negative bacteria and yet does not lead to significant reduction in assay 
sensitivity while increasing the proportion of interpretable results obtained (Albert et al., 
2007; Mole et al., 2007). Although the phage assay is simple to perform, inexpensive and 
does not require any sophisticated or dedicated equipment, it does require the samples to be  
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Fig. 4. Diagram of Phage Amplification Assay 
Grapic representation of the phage amplification assay. On the top the processing steps of 
the assay are presented and on the bottom the scientific details of the assay are shown. 
Following the appropriate sampling preparation the assay is carried out following the 
procedure described and presented in this figure.  
transferred to a dedicated microbiology laboratory. This was perceived to be a disadvantage 
over conventional sputum smear testing when diagnosis was being performed in clinics in 
remote areas where reliable, temperature controlled transportation of samples is difficult 
(Mbulo et al., 2004; Prakash et al., 2009).  
The issue of specificity of the phage test arises from the fact that the test utilizes the broad 
host range of phage D29 to allow both slow growing and fast growing Mycobacteria to be 
infected. As discussed in relation to the Reporter Phage assays, additional tests are therefore 
required to determine if the cell detected is TB or a non-tuberculosis Mycobacterium spp. For 
the commercial phage assays a cut-off of 20 plaques is applied, which is the expected 
number of plaques that will result from the presence of non-pathogenic Mycobacteria that 
have been fortuitously introduced into sputum, so that samples with fewer than 20 plaques 
are scored as negative. Patients with active disease generally produced samples with much 
higher plaque numbers due to growth of the bacteria. However Stanley et al. (2007) have 
demonstrated that PCR can also be used to increase the specificity of the D29 phage 
amplification assay.  
In this report the assay was being used for the detection of MAP in raw milk samples, but 
the presence of other pathogenic or non-pathogenic Mycobacteria in these samples could 
not be ruled out. To overcome this problem, DNA was extracted from the center of the 
plaques formed at the end of the assay and used for PCR amplification of signature 
sequences so that the identity of the cell detected by the phage could be determined (see 
Figure 4). Since M. tuberculosis and M. bovis were both likely to be present in raw milk 
samples a multiplex plaque PCR assay was developed to allow simultaneous discrimination 
between these three organisms. The signature sequences chosen were all multicopy IS 
elements (MAP, IS900; TB complex IS6110 and IS1081) with the size of the PCR product 
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indicating which element had been amplified. Combining the phage assay with PCR 
provides a significant advantage over direct PCR detection methods since the phage test 
provides live/dead discrimination while the PCR assay achieves definitive molecular 
molecular identification of the cell detected.  
By reducing sample loss due to contamination by the introduction of antibiotic supplements 
and increasing the specificity of the phage-based test by combining with PCR, it should be 
possible that a rapid and robust assay format can be achieved. However the need to perform 
PCR increases the complexity, cost and time required to complete the assay and the 
usefulness of this combination assay has yet to be evaluated for clinical cases of TB.  
4. Antibiotic sensitivity testing 
While the usefulness of phage detection tests for direct identification of M. tuberculosis in 
clinical samples remains questionable, the use of both Reporter Phage and PAA/PhaB 
assays for determining antibiotic susceptibility of clinical isolates has proven to be more a 
valuable tool. The principle of these tests was first outlined by Jacobs et al. (1993) using 
Reporter Phage when they demonstrated that phage growth and gene expression was 
inhibited if rifampicin was added to antibiotic-sensitive cells whereas if the cells were 
resistant to the antibiotic, signal generation was unaffected. They showed that the reporter 
gene signal could be detected within minutes of infection of M. tuberculosis with a Fflux 
Reporter Phage, and by comparing the results of Reporter Phage infection in the presence 
and absence of the antibiotic, the sensitivity of M. tuberculosis isolates could be determined 
within days. As before, this type of assay is not specific to M. tuberculosis and Williams et al. 
(1999) described the use of Fflux Reporter phage to rapidly determination of drug 
susceptibilities of MAP giving faster results and, in this case, also being used to determine 
the minimum inhibitory concentration (MIC) of the antibiotics tested more rapidly and 
accurately.  
Similar assays have been developed for the non-recombinant phage assays by showing that 
phage growth is inhibited, but in this case it is the formation of plaques that is inhibited 
rather than the signal from a reporter gene (Wilson et al., 1997 and reviewed in Minion and 
Pai, 2010), and again these have been produced as a commercial test (FASTplaque-
Response™; www.biotec.com) which can be used on direct patient specimens as well as 
indirect isolates. Other assay formats using microtitre plates and alternative methods of 
detecting phage growth have also been described (Gali et al., 2003; McNerney et al., 2007;, 
which have been designed to shorten the time required for testing. Most recently Bainee et 
al., (2008) have described a microtitre format Reporter Phage assay that can be semi-
automated. Isolates were inoculated in to the wells of the microtitre dish, treated with either 
rifampicin (RIF), isoniazid (INH) or no antibiotic and then incubated for 40 h before samples 
were infected with the TM4-based Reporter Phage phAE142. After 3 h of infection the light 
levels in each well are determined using a microplate luminometer and the sensitivity of the 
strains determined by comparing the light levels of the treated and control samples. This 
method was shown to be able to determine both the RIF and INH resistance of clinical 
isolates of M. tuberculosis with a median test result time of 2 days.  
Minion and Pai (2010) carried out a meta-analysis of 31 studies describing the use of the 
different phage assays used to determine rifampicin resistance and concluded that the 
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Reporter Phage assays had the highest accuracy (sensitivity = 99.3%, specificity = 98.6%), 
with in-house phage amplification assays also performing well (sensitivity = 98.5%, 
specificity = 97.9%). Estimates from studies evaluating the commercial FASTplaque kits 
were slightly lower (sensitivity = 95.5%, specificity = 95.0%); however, this difference was 
not statistically significant (based on overlapping confidence intervals) from the LRP and in-
house assays (Minion and Pai, 2010). However this report did highlight the fact that the 
phage-based methods currently provide the fastest phenotypic assay for antibiotic 
susceptibility testing and if levels of technical failure can be reduced these assays could be a 
useful clinical tool to improve patient outcomes.  
5. Enumeration assays 
Perhaps the most overlooked potential of these phage based assays is as a research tool for 
the rapid evaluation of viable count of laboratory cultures. Simple modifications of the 
Phage Amplification assay allow cell number to be rapidly determined, with results being 
available within 24 h. This method was first reported by Stanley et al. (2007) in a paper 
describing the development of a phage amplification assay for MAP. In this case 10-fold 
serial dilutions of MAP cultures were prepared and a sample of each dilution tested using 
the Phage Amplification assay and it was found that the number of plaques detected 
correlated well with the number of MAP cells in the test sample (Stanley, 2005). Rather than 
diluting the sample and testing each one, a modification of the FASTplaque assay method 
was devised that allowed the viable count of a sample containing an unknown number of 
cells. In this case the sample is simply diluted immediately prior to plating so that the 
plaque number can be accurately counted and then the number of cells present in the 
original sample determined according to the dilution factor (Botsaris et al., 2009; Figure 5).  
 
Fig. 5. Extraction of Plaques and Molecular Identification 
Schematic representation of the plaque extraction method. The plaques containing the 
genome of the initial targeted cell are extracted using a sterile loop. The loop is used to cut 
gently all 4 sides of the plaque area and then the plaque is gently lifted and placed into a 
PCR tube for DNA extraction.  
It is clear that there is not always a 1:1 relationship between the cfu and pfu counts obtained, 
however results for a given isolate grown under the same conditions seem to be relatively 
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constant (Stanley, 2005). Foddai et al. (2009) described the optimisation of the MAP Phage 
Amplification assay to accurately detect and enumerate MAP cells. They investigated the 
optimal buffer conditions for D29 phage infection of MAP cells, determined the minimal 
time for D29 incubation with MAP to produce extracellular phage (burst time) and the 
incubation time required before virucide treatment and assessed the impact of changing 
these parameters on the correlation between plaque count and corresponding colony count. 
To achieve a correlation closer to 1:1 between pfu/ml and cfu/ml value when detecting 
MAP, the authors suggested modifications to the standard protocol including 
supplementing the medium with 2 mM calcium chloride to enhance phage infection, 
incubating cells at 37 °C overnight before infection with D29 and extending the time allowed 
for phage infection to 2 h so that phage successfully infect a higher percentage of cells.  
 
Fig. 6. Modification of the PAA for Enumeration of cells 
Enumeration of cells using the PAA. 1 ml of the sample is infected with phage. Following 
adsorption exogenous phage are destroyed by the addition of a virucide which is then 
neutralised. Serial dilutions are made and plated on a lawn of M. smegmatis cells. Plaques 
(representing the target cells) are enumerated after overnight incubation.  
A limited number of reports of the use of phage for enumeration have appeared in the 
literature – all for MAP rather than for M. tuberculosis – but these do demonstrate the 
usefulness of the method, especially when following inactivation kinetics. Altic et al. (2007) 
used the FPTB assay in UV inactivation studies and the authors observed that the colony 
counts were consistently 1 to 2 log10 higher than the plaque counts. However the rate of 
inactivation measured by both culture and Phage Amplification Assay were identical, so 
that even though a proportion of the population was detected, these cells were inactivated 
in the same rate as the rest of the culture. Similarly Donaghy et al. (2009) used the Phage 
Amplification assay to monitor UV inactivation of MAP using a novel pilot-scale UV 
treatment for milk. Again there was a discrepancy between the cfu and pfu values obtained, 
and some evidence of large differences in the infectivity of different strains of MAP, but 
despite this the inactivation curves obtained were identical and the pfu data was available 
within 24 h whereas the culture results required up to 18 weeks for growth of the colonies. 
This demonstrates the power of the phage-based assays to provide rapid data to allow 
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development of experimental design to initiate new areas of research. Once the normal 
pfu:cfu ratio has been established for a particular strain grown under a particular condition, 
the phage assay can be used to rapidly determine the number of viable cells present in a 
sample without the need for extended periods of incubation. 
6. Conclusion 
The use of bacteriophage to type bacterial cells has been accepted as a standard 
microbiological method for many decades. First reports of the use of this technique for 
Mycobacteria appear in the 1960’s and it continued to be used as a standard method for 
investigations of epidemiological investigations until the 1980’s (see Snider et al., 1984). 
However the advent of molecular methods of identification and subtyping has made such 
phage-based methods obsolete. The difficulty of culturing with these slow growing and 
fastidious bacteria may have driven the development of alternative methods for detection 
and identification. To this end the rapid growth of phage within these cells has been 
exploited to produce a range of different assay methods and assay formats, all with the aim 
of producing rapid, simple, economic tests that can be adopted in areas where more 
expensive molecular diagnostic tests cannot be supported. However to date none of these 
has gained widespread acceptance in the clinical setting. Perhaps this is because all of these 
methods still require a degree of staff expertise to be able to perform the tests and therefore 
they do not yet fulfil the criteria required to be of use in less developed countries. However 
there is potential for these assays to be used effectively as an adjunct to standard culture 
methods to further our understanding of Mycobacteria, and perhaps as our understanding 
of the phage-host interaction increases we may be able to solve some of the limitations of the 
current phage based assays and allow them to eventually realise their potential in 
combating human disease.  
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